The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors.
CONCLUSION: Copay assistance reduced the patient cost burden for ALKis and was associated with patients picking up their ALKi prescriptions, beginning ALKi treatment sooner, and remaining on treatment.
PMID: 30729850 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Economics | Genetics | Health Management | Lung Cancer | Lymphoma | Non-Small Cell Lung Cancer | Oral Cancer | Study | USA Health